Volume 3, Emitir 6 (2013)
Revisão: Resultados da Trilha Clínica
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Artigo de edição especial
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Perspectiva Terapêutica
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Revisão: Resultados da Trilha Clínica
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Editorial
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Revisão: Resultados da Trilha Clínica
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Notícias e visualizações
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
